Navigation Links
BellBrook Labs and Tecan Offer Webinar on Screening Epigenetic Targets
Date:7/14/2013

Madison, WI (PRWEB) July 14, 2013

Join us for a webinar on July 17, 2013 at 12:00 PM EDT:

Tools for Screening Chromatin Modifying Enzymes

Register now: https://attendee.gotowebinar.com/register/503711917036579328

Biochemical HTS assays are a critical component of drug discovery programs focused on epigenetic drug targets like methyltransferases, acetyltransferases or kinases. Assembling high quality assay reagents and validating them on a detection platform that can deliver speed, accuracy and reproducibility can consume a significant amount of time and resources. The shift toward screening focused libraries against multiple targets in parallel can add to the assay development burden substantially.

In this webinar you will learn:

  • How a few different Transcreener HTS Assays allow robust, initial velocity detection of hundreds of chromatin modifying enzymes, including methyltransferases, acetyltransferases, kinases, glycosyltransferases, and SUMO ligases.
  • How to sync Transcreener assays with Tecan’s plate readers to generate high quality screening or profiling data.
  • How to eliminate costly biochemical assay development using turnkey kits combining Transcreener assays and pre-calibrated kinase and methyltransferase enzymes and substrates.

Participants should come away confident that they can apply a robust, cost-effective, user friendly solution to immediately begin screening or profiling chromatin modifying enzymes.

After registering, you will receive a confirmation email containing information about joining the webinar.

About BellBrook Labs. BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions for enzymes and phenotypic assays. The company’s Transcreener® HTS enzyme assays, used by all of the major pharmaceutical companies, make it easy to screen thousands of different enzymes, including validated targets like kinases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. The iuvo™ Microconduit Array technology and assay screening service is a line of unique microscale devices for miniaturization and automation of advanced cell models that are more representative of human physiology.

About Tecan. Tecan (http://www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10924304.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits
2. BellBrook Labs and BMG Labtech to Offer Webinar on Integrated Platform for Screening Kinases and Methyltransferases
3. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
4. Jennerex Announces First Patient Treated in Phase 1/2 Clinical Trial of JX-594 in Combination with Irinotecan in Patients with Metastatic Colorectal Cancer
5. Poliwogg’s Greg Simon Says Lifting of SEC Solicitation Ban for Private Offerings Will Vastly Expand Healthcare Investment
6. Vetter Offers a Sterile Water-for-injection Solution with 5 Years Stability Data
7. Cellular Dynamics International Announces Launch of Initial Public Offering
8. Intrexon Announces Filing of Registration Statement For Proposed Initial Public Offering
9. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
10. Intercept Pharmaceuticals Announces Completion of Public Offering and Exercise of Option to Purchase Additional Shares
11. St. Josephs Hospital is the First in Florida to Offer Non-invasive Test to Predict Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... June 28, 2017 Michael Zasloff , ... University School of Medicine, and Founder, Chairman and CEO ... study that has helped clarify the function of alpha-Synuclein ... other neurodegenerative diseases. Denise Barbut , MD, FRCP, ... was senior co-author of the study. Published ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... three research projects accepted for presentation at the 33rd Annual Meeting of the ... – including some of the world’s top thought leaders in reproductive medicine – ...
(Date:6/28/2017)... and London, June 28, 2017 (PRWEB) , ... ... ... The latest release of Siemens’ STAR-CCM+® software for multiphysics computational fluid ... enable automated product design exploration and optimization. STAR-CCM+ version 12.04 introduces Design ...
(Date:6/28/2017)... NC (PRWEB) , ... June 28, 2017 , ... Studies ... might lead to an effective treatment for Parkinson’s disease. But what has not been ... should take place to gain the best results. , A new study coming out ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... March 28, 2017 The report ... (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), ... - Global Forecast to 2022", published by MarketsandMarkets, the ... and is projected to reach USD 75.64 Billion by ... 2022. The base year considered for the study is ...
(Date:3/23/2017)... , Mar. 23, 2017 Research and Markets ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 8.8% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
Breaking Biology News(10 mins):